In this segment, Jeffrey D. Dunn, PharmD, MBA, and Yehuda Handelsman, MD, FACP, FACE, FNLA, comment that traditional diabetes management techniques, such as distributing newsletters and brochures to patients, have not improved overall adherence rates to therapy among patients with type 2 diabetes mellitus.
Dr Handelsman adds that most patients discard pamphlets without ever reviewing them, and suggests that other adherence-promoting measures may be more effective.
Peter Salgo, MD; Maria Lopes, MD, MS; and Drs Dunn and Handelsman emphasize the importance of social support for patients with diabetes. Dr Lopes explains that social support programs need to be tailored specifically for each individual patient, because different patients have different needs.
Together, the panelists discuss the importance of coordination of care among all stakeholders involved in the patient’s care, including physicians, nurses, dietitians, pharmacists, and health plans. Dr Lopes explains that providers need to work as a team to educate, train, motivate, and assess the patient as an individual and help them throughout the entire treatment process.
Kari Uusinarkaus, MD, FAAFP, FNLA, describes a program that allows patients with diabetes to go shopping with a dietitian in a grocery store. However, Dr Salgo asks about the costs of such a program.
Drs Dunn and Handelsman argue that although programs to improve patient adherence are costly, they are important. Dr Dunn adds that it is more cost-effective to prevent diabetes than to treat it.
Joanne Mizell: Lifestyle Modification Programs Take Holistic Aim at Metabolic Disease
May 1st 2024Joanne Mizell shares insurer strategies in addressing the escalating rates of metabolic diseases, highlighting the importance of holistic treatment methods like lifestyle modification programs, which integrate nutrition, physical activity, and community engagement.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
USPSTF Lowers Age for Biennial Mammograms to 40, Citing Early Detection Benefit
April 30th 2024The USPSTF lowered the recommended starting age for mammograms from 50 to 40 years, citing moderate benefits for early detection in this age group. Disparities persist, especially for Black women, highlighting the need for improved access to health care and social support.
Read More
Makers of medical tests will have about 4 years to show the FDA that their new offerings deliver accurate results; after previously decreasing for 27 years, US tuberculosis (TB) cases increased every year since 2020; a US district judge rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to the Medicare drug price negotiation program.
Read More